Pharmacokinetics of bendroflumethiazide after low oral doses
- 1 August 1981
- journal article
- research article
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 9 (4) , 431-441
- https://doi.org/10.1007/bf01060887
Abstract
The pharmacokinetics of bendroflumethiazide after oral administration of 1.25, 2.5, and 5.0 mg were studied in nine healthy male volunteers. Bendroflumethiazide was analyzed by GLC after extractive alkylation. After the lowest dose, the plasma concentration could be followed to 14 hr, and the data were adequately fitted by a one-compartment model; the half-life was 3.1 hr. After the 2.5 and 5.0 mg doses, the plasma concentration was followed for 24 hr, and the data were fitted by a two-compartment model with half-lives of 8.9 hr. The urinary sodium concentration was doubled after bendroflumethiazide intake, but the urinary potassium concentration remained almost constant. The renal clearance of bendroflumethiazide was around 30 ml · min −1 .Keywords
This publication has 7 references indexed in Scilit:
- Extractive alkylation of sulphonamide diuretics and their determination by electron-capture gas chromatographyJournal of Chromatography A, 1979
- Pharmacokinetics of bendroflumethiazide in hypertensive patientsEuropean Journal of Clinical Pharmacology, 1978
- Pharmacokinetics of bendroflumethiazideClinical Pharmacology & Therapeutics, 1977
- A GLC assay for bendroflumethiazide. Preliminary data about its plasma level in manEuropean Journal of Clinical Pharmacology, 1976
- S35-Labeled Bendroflumethiazide in Human BeingsArchives of internal medicine (1960), 1964
- PHARMACOLOGY OF BENZYDROFLUMETHIAZIDE (NATURETIN)1961
- Pharmacologic observations on a more potent benzothiadiazine diuretic (Be. 724-A)American Heart Journal, 1960